O'Mahony S, Arranz E, Barton J R, Ferguson A
University of Edinburgh, Gastrointestinal Unit, Western General Hospital, Edinburgh.
Gut. 1991 Jan;32(1):29-35. doi: 10.1136/gut.32.1.29.
We examined humoral immunity in coeliac disease as expressed in serum (systemic immunity), and in saliva, jejunal aspirate, and whole gut lavage fluid (mucosal immunity). The aims were to define features of the secretory immune response (IgA and IgM concentrations and antibody values to gliadin and other food proteins measured by enzyme linked immunosorbent assay (ELISA)) in active disease and remission, and to establish whether secretions obtained by relatively non-invasive techniques (saliva and gut lavage fluid) can be used for indirect measurements of events in the jejunum. Serum, saliva, and jejunal aspirate from 26 adults with untreated coeliac disease, 22 treated patients, and 28 immunologically normal control subjects were studied, together with intestinal secretions obtained by gut lavage from 15 untreated and 19 treated patients with coeliac disease and 25 control subjects. Jejunal aspirate IgA and IgM and gut lavage fluid IgM concentrations were significantly raised in patients with untreated coeliac disease; the lavage fluid IgM concentration remained higher in patients with treated coeliac disease than in controls. Serum and salivary immunoglobulin concentrations were similar in the three groups. Patients with untreated coeliac disease had higher values of antibodies to gliadin compared with treated patients and control subjects in all body fluids tested; these were predominantly of IgA and IgG classes in serum, and of IgA and IgM classes in jejunal aspirate and gut lavage fluid. Values of salivary IgA antibodies to gliadin were significantly higher in untreated coeliacs, though antibody values were generally low, with a large overlap between coeliac disease patients and control subjects. In treated patients, with proved histological recovery on gluten free diet, serum IgA antigliadin antibody values fell to control values, though serum IgG antigliadin antibody values remained moderately raised. In contrast, there was persistence of secretory antigliadin antibodies in treated patients (particularly IgM antibody) in both jejunal aspirate and gut lavage fluid. Antibody responses to betalactoglobulin and ovalbumin were similar to those for gliadin, including persistence of high intestinal antibody values in patients with treated coeliac disease. There was a positive correlation between antibody values in jejunal aspirate and gut lavage fluid, but not between saliva and jejunal aspirate; thus salivary antibodies do not reflect intestinal humoral immunity.
我们研究了乳糜泻患者血清(全身免疫)、唾液、空肠抽吸物和全肠道灌洗液(黏膜免疫)中表达的体液免疫。目的是确定活动性疾病和缓解期分泌性免疫反应的特征(通过酶联免疫吸附测定(ELISA)测量的IgA和IgM浓度以及针对麦醇溶蛋白和其他食物蛋白的抗体值),并确定通过相对非侵入性技术(唾液和肠道灌洗液)获得的分泌物是否可用于间接测量空肠中的情况。研究了26名未经治疗的乳糜泻成年患者、22名接受治疗的患者和28名免疫正常对照者的血清、唾液和空肠抽吸物,以及15名未经治疗和19名接受治疗的乳糜泻患者和25名对照者通过肠道灌洗获得的肠道分泌物。未经治疗的乳糜泻患者空肠抽吸物中的IgA和IgM以及肠道灌洗液中的IgM浓度显著升高;接受治疗的乳糜泻患者灌洗液中的IgM浓度仍高于对照组。三组患者血清和唾液免疫球蛋白浓度相似。在所有检测的体液中,未经治疗的乳糜泻患者针对麦醇溶蛋白的抗体值高于接受治疗的患者和对照者;这些抗体在血清中主要为IgA和IgG类,在空肠抽吸物和肠道灌洗液中为IgA和IgM类。未经治疗的乳糜泻患者唾液中针对麦醇溶蛋白的IgA抗体值显著更高,尽管抗体值通常较低,乳糜泻患者和对照者之间有很大重叠。在接受治疗的患者中,经无麸质饮食组织学证实恢复后,血清IgA抗麦醇溶蛋白抗体值降至对照值,尽管血清IgG抗麦醇溶蛋白抗体值仍适度升高。相比之下,接受治疗的患者空肠抽吸物和肠道灌洗液中分泌性抗麦醇溶蛋白抗体(特别是IgM抗体)持续存在。对β-乳球蛋白和卵清蛋白的抗体反应与对麦醇溶蛋白的反应相似,包括接受治疗的乳糜泻患者肠道抗体值持续偏高。空肠抽吸物和肠道灌洗液中的抗体值呈正相关,但唾液和空肠抽吸物之间无相关性;因此,唾液抗体不能反映肠道体液免疫。